Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

BIO

- PMLiVE

Industry pleads for compromise after Brexit defeat

Prime Minister is more boxed in than ever, but unlikely to be toppled

The UK’s new five-year pricing agreement

Pharma has agreed to capped growth again - in exchange for uptake promises

- PMLiVE

Crunch time as Brexit deal faces ‘meaningful vote’

Rejecting the deal would either result in a no deal or no Brexit, warns May

- PMLiVE

Blackwood returns as new life sciences minister

Replaces James O’Shaughnessy at DHSC

- PMLiVE

Time running out for ‘no-deal’ Brexit medicines laws

Needs parliament clearance before 29 March

Bear and Two Foxes

Givers and Takers

Have we lost the ability to identify the difference between net givers and net takers of energy?

Page & Page and Partners

Q&A with Dr Timothy Vollmer, leading MS Neurologist

Blue Latitude Health sits down with key opinion leader and specialist neurologist Dr Timothy Vollmer to better understand the paradigm shift in MS treatment. He explains the challenges neurologists face...

Blue Latitude Health

- PMLiVE

Drug pricing is pharma’s top concern in 2019

More than half of industry respondents say pricing will have the greatest negative impact this year

- PMLiVE

Pharma’s confidence in Brexit deal falls as vote looms

Most EMIG members have little or no confidence in the government’s abilities to obtain a good deal

- PMLiVE

Post-Brexit immigration policy has a critical missing piece

ABPI welcomes focus on skills, but UK must respond fast to skills gaps

- PMLiVE

Business warning as talk of Brexit ‘No deal’ grows

'Managed no deal' plan is 'not a credible position' warns business

- PMLiVE

NICE appraisal fees to be introduced despite opposition

Concessions made for small companies

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links